Matches in SemOpenAlex for { <https://semopenalex.org/work/W2656711503> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W2656711503 abstract "Background Rheumatoid Arthritis (RA) should be treated instantly to prevent further joint destruction. The first few months after treatment initiation are critical for long-term treatment outcome.[1]Patients with RA are at increased risk of thyroid disease with direct effect on initial treatment response.[2] Objectives To define the prevalence of thyroid disease among RA patients as well as to evaluate the correlation between presence of thyroid disease in RA patients and initial treatment response. Methods All RA patients who were registered in the local part of Danish Danbio registry were included in this study. Patients9 demographic data, serology results including rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (anti-ccp) as well as disease activity score in 28 joints-C-reactive protein (DAS28-CRP) at the time of diagnosis and after 4 months (±1–2 months) of treatment initiation were extracted. ΔDAS28 was calculated as follows: DAS28 at the time of diagnosis – DAS28 after 4 months (±1–2 months) of treatment initiation. Patients9 electronic hospital records including laboratory results were reviewed to reveal if they had been diagnosed with thyroid disease. Results 1035 patients were included in the study (Table 1). Prevalence of thyroid disease was 11.8% (122/1035). Multiple linear regression analysis showed a negative correlation between ΔDAS28 and presence of thyroid disease adjusted for age, gender, disease duration, RF, anti-ccp and DAS28 at the time of diagnosis (Regression coefficient (95% Confidence Interval): -0,157 (-0.312 to -0.002), P=0.047) (Table 2). RA patients with thyroid disease had significantly poorer initial response to RA treatment compared to patients with isolated RA after 4 months of treatment (P=0.002). Conclusions Presence of thyroid disease in RA patients worsens initial treatment response and is suggestive of poor long-term prognosis. The authors propose routine measurement of serum thyroid stimulating hormone (TSH) in all RA patients at the time of diagnosis and with yearly interval. References Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023–2038. doi: 10.1016/S0140–6736(16)30173–8. Joshi P, Agarwal A, Vyas S, et al. Prevalence of hypothyroidism in rheumatoid arthritis and its correlation with disease activity. Trop Doct 2017;47:6–10. Acknowledgements We thank Mrs. Maryam Mousavi for her contribution to data collection. Disclosure of Interest None declared" @default.
- W2656711503 created "2017-06-30" @default.
- W2656711503 creator A5013001379 @default.
- W2656711503 creator A5017600145 @default.
- W2656711503 creator A5041421770 @default.
- W2656711503 creator A5041728162 @default.
- W2656711503 date "2017-06-01" @default.
- W2656711503 modified "2023-10-17" @default.
- W2656711503 title "FRI0137 Presence of thyroid disease in rheumatoid arthritis patients is predictor of worse initial treatment response: an observational, cohort study" @default.
- W2656711503 doi "https://doi.org/10.1136/annrheumdis-2017-eular.3271" @default.
- W2656711503 hasPublicationYear "2017" @default.
- W2656711503 type Work @default.
- W2656711503 sameAs 2656711503 @default.
- W2656711503 citedByCount "0" @default.
- W2656711503 crossrefType "proceedings-article" @default.
- W2656711503 hasAuthorship W2656711503A5013001379 @default.
- W2656711503 hasAuthorship W2656711503A5017600145 @default.
- W2656711503 hasAuthorship W2656711503A5041421770 @default.
- W2656711503 hasAuthorship W2656711503A5041728162 @default.
- W2656711503 hasBestOaLocation W26567115031 @default.
- W2656711503 hasConcept C126322002 @default.
- W2656711503 hasConcept C201903717 @default.
- W2656711503 hasConcept C2776232647 @default.
- W2656711503 hasConcept C2776652619 @default.
- W2656711503 hasConcept C2777575956 @default.
- W2656711503 hasConcept C2779134260 @default.
- W2656711503 hasConcept C2780176905 @default.
- W2656711503 hasConcept C44249647 @default.
- W2656711503 hasConcept C526584372 @default.
- W2656711503 hasConcept C71924100 @default.
- W2656711503 hasConcept C72563966 @default.
- W2656711503 hasConceptScore W2656711503C126322002 @default.
- W2656711503 hasConceptScore W2656711503C201903717 @default.
- W2656711503 hasConceptScore W2656711503C2776232647 @default.
- W2656711503 hasConceptScore W2656711503C2776652619 @default.
- W2656711503 hasConceptScore W2656711503C2777575956 @default.
- W2656711503 hasConceptScore W2656711503C2779134260 @default.
- W2656711503 hasConceptScore W2656711503C2780176905 @default.
- W2656711503 hasConceptScore W2656711503C44249647 @default.
- W2656711503 hasConceptScore W2656711503C526584372 @default.
- W2656711503 hasConceptScore W2656711503C71924100 @default.
- W2656711503 hasConceptScore W2656711503C72563966 @default.
- W2656711503 hasLocation W26567115031 @default.
- W2656711503 hasOpenAccess W2656711503 @default.
- W2656711503 hasPrimaryLocation W26567115031 @default.
- W2656711503 isParatext "false" @default.
- W2656711503 isRetracted "false" @default.
- W2656711503 magId "2656711503" @default.
- W2656711503 workType "article" @default.